DE3926606A1
(de)
|
1989-08-11 |
1991-02-14 |
Hoechst Ag |
Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
|
DE4130514A1
(de)
|
1991-09-13 |
1993-03-18 |
Chemie Linz Deutschland |
Verfahren zur herstellung reiner n,n'-unsymmetrisch substituierter phenylharnstoffe
|
US5532243A
(en)
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
US5312814A
(en)
|
1992-12-09 |
1994-05-17 |
Bristol-Myers Squibb Co. |
α-phosphonocarboxylate squalene synthetase inhibitors
|
DE4341403A1
(de)
|
1993-12-04 |
1995-06-08 |
Basf Ag |
N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
WO1997017954A1
(en)
|
1995-11-13 |
1997-05-22 |
Albany Medical College |
Analgesic compounds and uses thereof
|
CA2249601A1
(en)
|
1996-04-03 |
1997-10-23 |
Thorsten E. Fisher |
Inhibitors of farnesyl-protein transferase
|
CA2282654C
(en)
|
1997-03-03 |
2009-02-03 |
Eisai Co., Ltd. |
Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
|
CA2319198C
(en)
|
1998-01-27 |
2011-02-22 |
Aventis Pharmaceuticals Products Inc. |
Substituted oxoazaheterocyclyl factor xa inhibitors
|
EP1087937A1
(en)
|
1998-06-17 |
2001-04-04 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
CA2346006A1
(en)
|
1998-10-09 |
2000-04-20 |
Merck & Co., Inc. |
Delta 6 fatty acid desaturase
|
EP1146790A4
(en)
|
1999-01-25 |
2004-03-17 |
Smithkline Beecham Corp |
COMPOUNDS AND METHODS
|
CA2369822A1
(en)
|
1999-04-14 |
2000-10-19 |
Merck & Co., Inc. |
Novel human voltage-gated potassium channel
|
KR20020002501A
(ko)
|
1999-05-13 |
2002-01-09 |
시오노 요시히코 |
당뇨병의 예방 또는 치료약
|
CA2374793A1
(en)
|
1999-05-24 |
2000-11-30 |
Penglie Zhang |
Inhibitors of factor xa
|
CN1420882A
(zh)
|
1999-07-28 |
2003-05-28 |
阿温蒂斯药物公司 |
取代的氧代氮杂杂环基化合物
|
US6372793B1
(en)
|
1999-08-20 |
2002-04-16 |
Florida Agricultural & Mechanical University |
Method for treatment of a neurological disease characterized by impaired neuromodulator function
|
MY125533A
(en)
*
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
DK1311272T3
(da)
|
2000-03-03 |
2007-02-26 |
Eisai R&D Man Co Ltd |
Hidtil ukendte fremgangsmåder hvor der anvendes cholinesteraseinhibitorer
|
US20020045613A1
(en)
|
2000-04-27 |
2002-04-18 |
Heinz Pauls |
1-aroyl-piperidinyl benzamidines
|
WO2001087921A2
(en)
|
2000-05-16 |
2001-11-22 |
Merck & Co., Inc. |
Gene responsible for stargardt-like dominant macular dystrophy
|
WO2002005819A1
(en)
|
2000-07-15 |
2002-01-24 |
Smithkline Beecham Corporation |
Compounds and methods
|
US6962936B2
(en)
|
2001-04-27 |
2005-11-08 |
Vertex Pharmaceuticals Incorporated |
Triazole-derived kinase inhibitors and uses thereof
|
JP2004532899A
(ja)
|
2001-07-06 |
2004-10-28 |
ニューロサーチ、アクティーゼルスカブ |
新規化合物、その製造方法及びその使用方法
|
WO2003024450A1
(en)
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating prion diseases
|
WO2003024456A1
(en)
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating and preventing migraines
|
WO2003032914A2
(en)
|
2001-10-17 |
2003-04-24 |
Eisai Co., Ltd. |
Methods for treating substance abuse with cholinesterase inhibitors
|
WO2003066581A1
(en)
|
2002-02-05 |
2003-08-14 |
Eli Lilly And Company |
Urea linker derivatives for use as ppar modulators
|
US20030195192A1
(en)
|
2002-04-05 |
2003-10-16 |
Fortuna Haviv |
Nicotinamides having antiangiogenic activity
|
IL164007A0
(en)
|
2002-03-13 |
2005-12-18 |
Janssen Pharmaceutica Nv |
New inhibitors of histone deacetylase
|
AU2003228796A1
(en)
|
2002-05-01 |
2003-11-17 |
Eisai Co., Ltd. |
Cholinesterase inhibitors to prevent injuries caused by chemicals
|
AU2003298514A1
(en)
|
2002-05-17 |
2004-05-04 |
Eisai Co., Ltd. |
Methods and compositions using cholinesterase inhibitors
|
EP2508204B1
(en)
|
2002-06-26 |
2014-09-24 |
Ono Pharmaceutical Co., Ltd. |
Remedies for diseases caused by vascular contraction or dilation
|
MXPA05000947A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
|
WO2004010942A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
AU2003255845A1
(en)
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
US7196082B2
(en)
|
2002-11-08 |
2007-03-27 |
Merck & Co. Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US7501405B2
(en)
*
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
JP2006522750A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法
|
US7700583B2
(en)
*
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
US20060287394A1
(en)
|
2003-05-30 |
2006-12-21 |
Konstantin Petrukhin |
Composition and method for treating macular disorders
|
WO2004110996A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
FR2857363B1
(fr)
*
|
2003-07-10 |
2007-09-07 |
Aventis Pharma Sa |
4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
WO2005074535A2
(en)
|
2004-01-30 |
2005-08-18 |
Eisai Co., Ltd. |
Cholinesterase inhibitors for spinal cord disorders
|
US7435831B2
(en)
|
2004-03-03 |
2008-10-14 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
WO2005087226A1
(en)
|
2004-03-05 |
2005-09-22 |
Eisai Co., Ltd. |
Cadasil treatment with cholinesterase inhibitors
|
BRPI0511295A
(pt)
|
2004-05-18 |
2007-12-04 |
Schering Corp |
2-quinolil-oxazóis substituìdos úteis como inibidores de pde4
|
FR2872416B1
(fr)
|
2004-07-01 |
2006-09-22 |
Oreal |
Utilisation de derives de piperidine pour lutter contre les rides
|
JPWO2006004201A1
(ja)
|
2004-07-01 |
2008-04-24 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
神経再生促進剤
|
WO2006015737A1
(de)
|
2004-08-02 |
2006-02-16 |
Schwarz Pharma Ag |
Carboxamide des indolizins und seiner aza- und diazaderivate
|
JP2006077006A
(ja)
|
2004-08-13 |
2006-03-23 |
Eisai Co Ltd |
加齢に伴う過活動膀胱治療薬
|
WO2006033734A2
(en)
|
2004-08-18 |
2006-03-30 |
Sirion Therapeutics, Inc. |
Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
|
JP4639696B2
(ja)
|
2004-08-31 |
2011-02-23 |
Jsr株式会社 |
磁性体複合粒子およびその製造方法
|
WO2006034446A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
|
MX2007003332A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
|
BRPI0517378A
(pt)
|
2004-10-27 |
2008-10-07 |
Janssen Pharmaceutica Nv |
moduladores de tetraidro piridinil pirazol canabinóide
|
EP1807103A4
(en)
|
2004-11-04 |
2009-02-11 |
Sirion Therapeutics Inc |
MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION
|
MX2007006178A
(es)
|
2004-11-23 |
2007-06-20 |
Ptc Therapeutics Inc |
Fenoles substituidos como agentes activos que inhiben la produccion del factor de crecimiento endotelial vascular.
|
JP2006176503A
(ja)
|
2004-11-26 |
2006-07-06 |
Tohoku Univ |
脳血管障害を伴うアルツハイマー病治療薬
|
EA011154B1
(ru)
|
2004-12-08 |
2009-02-27 |
Сирион Терапьютикс, Инк. |
Композиции для лечения ретинол-ассоциированных заболеваний
|
WO2006066879A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Devgen N.V. |
Compounds with kv4 ion channel activity
|
GB0503056D0
(en)
|
2005-02-14 |
2005-03-23 |
Smithkline Beecham Corp |
Chemical compounds
|
WO2006094235A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
AU2006244074B2
(en)
|
2005-05-09 |
2012-12-13 |
Hydra Biosciences, Inc. |
Compounds for modulating TRPV3 function
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
UA81382C2
(en)
|
2005-07-11 |
2007-12-25 |
|
Composition for treating retinol-related diseases by modulation of retinol binding
|
RU2422442C2
(ru)
*
|
2005-07-29 |
2011-06-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные индол-3-ил-карбонил-пиперидина и пиперазина
|
EP1923388A4
(en)
|
2005-08-12 |
2011-03-09 |
Takeda Pharmaceutical |
BRAIN / NERVE CELL PROTECTION AND THERAPEUTIC FOR SLEEP DISORDERS
|
US20090258862A1
(en)
|
2005-08-29 |
2009-10-15 |
Colletti Steven L |
Niacin receptor agonists, compositions containing such compounds and methods of treatment
|
EP2407453A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
PGD2 receptor antagonist
|
US7576106B2
(en)
|
2005-10-11 |
2009-08-18 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
DE102005049954A1
(de)
*
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
ES2407115T3
(es)
|
2005-11-18 |
2013-06-11 |
Ono Pharmaceutical Co., Ltd. |
Compuesto que contiene un grupo básico y uso del mismo
|
WO2007086584A1
(ja)
|
2006-01-30 |
2007-08-02 |
Meiji Seika Kaisha, Ltd. |
新規FabKおよびFabI/K阻害剤
|
US20070254911A1
(en)
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
CA2647545C
(en)
|
2006-04-03 |
2016-02-23 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
|
EP2027132B1
(en)
|
2006-05-18 |
2010-09-15 |
F. Hoffmann-La Roche AG |
Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
|
CA2665195C
(en)
|
2006-10-11 |
2011-08-09 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use thereof
|
ES2371784T3
(es)
|
2006-12-08 |
2012-01-10 |
F. Hoffmann-La Roche Ag |
Indoles.
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
DK2170340T3
(en)
|
2007-06-21 |
2016-03-14 |
Neuronascent Inc |
Methods and compositions for Stimulating neurogenesis and inhibition of neuronal degeneration BY USING ISOTHIAZOLOPYRIMIDINONER
|
US20120121540A1
(en)
|
2007-08-10 |
2012-05-17 |
Franz Ulrich Schmitz |
Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
|
US7973079B2
(en)
|
2007-09-27 |
2011-07-05 |
Revision Therapeutics, Inc. |
Methods and compounds for treating retinol-related diseases
|
WO2009042444A2
(en)
|
2007-09-27 |
2009-04-02 |
Sirion Therapeutics, Inc. |
Methods and compounds for treating retinol-related diseases
|
WO2009051244A1
(ja)
|
2007-10-18 |
2009-04-23 |
Takeda Pharmaceutical Company Limited |
複素環化合物
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
EP2295406B1
(en)
|
2008-05-30 |
2014-04-23 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
WO2014097304A1
(en)
|
2012-12-22 |
2014-06-26 |
Maytronics Ltd. |
Autonomous pool cleaning robot
|
MX2011002263A
(es)
|
2008-09-10 |
2011-05-23 |
Kalypsys Inc |
Aminopirimidinas como inhibidores de receptores de histamina para el tratamiento de enfermedades.
|
US20100168080A1
(en)
|
2008-12-17 |
2010-07-01 |
Khamrai Uttam |
Novel compounds useful as cc chemokine receptor ligands
|
JP6062633B2
(ja)
|
2009-01-28 |
2017-01-18 |
カラ セラピューティクス インコーポレイテッド |
二環式ピラゾロ複素環類
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
JP5642661B2
(ja)
*
|
2009-03-05 |
2014-12-17 |
塩野義製薬株式会社 |
Npyy5受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
|
TW201041868A
(en)
|
2009-03-20 |
2010-12-01 |
Intervet Int Bv |
Anthelmintic agents and their use
|
WO2010108268A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
JP2012523461A
(ja)
|
2009-04-13 |
2012-10-04 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
レチノール結合タンパク質4(rbp4)へのレチノールの結合を調節するための組成物および方法
|
BRPI1013763A2
(pt)
|
2009-04-16 |
2015-08-25 |
Takeda Pharmaceutical |
Composto ou sal do mesmo, prodroga, composição farmacêutica, agente diminuidor da proteína de ligação de retinol 4, agente para a profilaxia ou tratamento de diabetes, e, uso de um composto
|
MX2011012584A
(es)
|
2009-05-26 |
2012-02-21 |
Exelixis Inc |
Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
|
US8102887B2
(en)
|
2009-05-26 |
2012-01-24 |
Corning Incorporated |
Edge bonded optical packages
|
AR076928A1
(es)
|
2009-05-28 |
2011-07-20 |
Otsuka Pharma Co Ltd |
Derivados de 3h-pirido[4, 3-d]pirimidin-4-ona, un metodo para su preparacion, composiciones farmaceuticas que los comprenden y su uso en la manufactura de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el estres.
|
ES2540547T3
(es)
|
2009-09-16 |
2015-07-10 |
The University Of Edinburgh |
Compuestos de (4-fenil-piperidin-1-il)-[5-(1H-pirazol-4-il)-tiofen-3-il]-metanona y su uso
|
WO2011059881A1
(en)
|
2009-11-12 |
2011-05-19 |
The Trustees Of Columbia University In The City Of New York |
Treatment of ophthalmic conditions with fluorenone derivatives
|
CA2781888C
(en)
|
2009-12-11 |
2019-06-18 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
RU2581367C2
(ru)
|
2010-03-01 |
2016-04-20 |
Джи Ти Икс, ИНК. |
Соединения для лечения рака
|
WO2011116356A2
(en)
|
2010-03-19 |
2011-09-22 |
Sanford-Burnham Medical Research Institute |
Positive allosteric modulators of group ii mglurs
|
WO2011116123A1
(en)
|
2010-03-19 |
2011-09-22 |
Irm Llc |
Tafamidis for the treatment of ophthalmic diseases
|
WO2011149993A2
(en)
|
2010-05-25 |
2011-12-01 |
Abbott Laboratories |
SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
CA2803009A1
(en)
*
|
2010-07-01 |
2012-01-05 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
BR112013004623A2
(pt)
|
2010-08-27 |
2016-07-05 |
Novartis Ag |
"inibidores de desacetilases com base em hidroxamato."
|
EP2642998B1
(en)
|
2010-11-24 |
2020-09-16 |
The Trustees of Columbia University in the City of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
US9290453B2
(en)
|
2010-12-23 |
2016-03-22 |
Merck Sharp & Dohme Corp. |
Quinolines and aza-quinolines as CRTH2 receptor modulators
|
US9295676B2
(en)
|
2011-03-17 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Mutation mimicking compounds that bind to the kinase domain of EGFR
|
WO2012158844A1
(en)
|
2011-05-17 |
2012-11-22 |
Shionogi & Co., Ltd. |
Heterocyclic compounds
|
WO2013166041A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
Transthyretin ligands capable of inhibiting retinol-dependent rbp4-ttr interaction for treatment of age-related macular
|
US9333202B2
(en)
|
2012-05-01 |
2016-05-10 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
|
WO2013166040A1
(en)
|
2012-05-01 |
2013-11-07 |
The Trustees Of Columbia University In The City Of New York |
S-fta and s-fta analogues capable of inhibiting retinol-dependent rbp4-ttr interaction for treatment of age-related macular degeneration, stargardt disease, and other retinal disease characterized by excessive lipofuscin accumulation
|
TW201501713A
(zh)
*
|
2013-03-01 |
2015-01-16 |
Kyowa Hakko Kirin Co Ltd |
眼炎症性疾病之預防及/或治療劑
|
WO2014152018A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydrocyclopentapyrroles, their preparation and use
|
US9938291B2
(en)
|
2013-03-14 |
2018-04-10 |
The Trustess Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
US20160030422A1
(en)
|
2013-03-14 |
2016-02-04 |
Konstantin Petrukhin |
Rbp4 antagonists for the treatment of age-related macular degeneration and stargardt disease
|
US10273243B2
(en)
|
2013-03-14 |
2019-04-30 |
The Trustees Of Columbia University In The City Of New York |
4-phenylpiperidines, their preparation and use
|
EP3137168B1
(en)
*
|
2014-04-30 |
2022-01-05 |
The Trustees of Columbia University in the City of New York |
Substituted 4-phenylpiperidines, their preparation and use
|